Other reported autoantibodies in NMO include anti-MOG as mentioned above (23–27), NMDA-type glutamate receptor (e.g., CV2/CRMP5), and glycine receptor antibodies (53–55). This evidence concerns the gene DPYSL5 and neuromyelitis optica.